Therapeutic transcranial magnetic stimulation in migraine and its implications for a neuroinflammatory hypothesis

Inflammopharmacology

Volumn 17, Issue 2, 2009, Pages 68-75

  McComas, A ^a   Upton, A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CALCITONIN GENE RELATED PEPTIDE; CARBAMAZEPINE; NITRIC OXIDE; PROSTAGLANDIN E2;

AGED; BRAIN BLOOD FLOW; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG DOSE INCREASE; FAMILIAL HEMIPLEGIC MIGRAINE; FEMALE; GENE MUTATION; HUMAN; MIGRAINE; NERVOUS SYSTEM INFLAMMATION; NEURITIS; PATHOGENESIS; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SOMATOSENSORY CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESPONSE; TRIGEMINUS NEURALGIA;

ANIMALS; CLINICAL TRIALS AS TOPIC; HUMANS; MIGRAINE DISORDERS; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 64049099630     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-009-8058-7     Document Type: Review

References (58)

1. Aurora, S., et al. (1998). Transcranial magnetic stimulation confirms hyperexcitability of visual cortex in migraine. Neurology 50, 1105-1110.
2. Bahra, A., et al. (2001). Brainstem activation specific to migraine headache. Lancet 357, 1016-1017.
3. Barker, A.T., et al. (1985). Non-invasive magnetic stimulation of human motor cortex. Lancet 1, 1106-1107.
4. Bolay, H., et al (2002). Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat. Med. 8, 136-142.
5. Burstein, R. et al. (1998). Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J. Neurophysiol. 79, 964-982.
6. Burstein, R. (2001). Deconstructing migraine headache into peripheral and central sensitization. Pain 89, 107-110.
7. Clarke, B.M. et al. (2006). Transcranial magnetic stimulation for migraine: clinical effects. J. Headache Pain 7, 341-346.
8. Conti, F. et al. (1994). Calcitonin gene-related peptide (CGRP) in the cat neocortex: evidence for a sparse but widespread network of immunoreactive fibers. Cereb. Cortex 4, 97-105.
9. +pump alpha 2 subunit gene is responsible for familial hemiplegic migraine type 2. Nature Genet. 33, 192-196.
10. Dichgans, M. et al (2005). Mutation in the neuronal voltage-gated sodium, channel SCN1A causes familial hemiplegic migraine. Lancet 366, 371-377.
11. Edvinsson, L. and Uddman, R. (2005). Neurology in primary headaches. Brain Res. Rev. 48, 438-456.
12. Fisher, M.J. (2004). Goodbye headaches. A gun that shoots magnetic pulses puts an end to an age-old scourge. Discover (August), 28-29.
13. Fumal, A et al (2003). Transcranial magnetic stimulation in migraine: a review of facts and controversies. Acta Neurol. Belg. 103, 144-154.
14. Gallai, V. et al (1995). Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia 15, 384-390.
15. Gardner, K.L. (2006). Genetics of migraine: an update. Headache 46, S19-S24.
16. Gartside, S.E. et al (2000). Neurochemical and electrophysiological studies on the functional significance of burst firing in serotonergic neurons. Neuroscience 98, 295-300.
17. Goadsby, P.J. et al. (1998). Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann. Neurol. 23, 193-196.
18. Goadsby, P.J. et al. (1990). Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann. Neurol. 28, 183-187.
19. Goadsby, P.J. and Edvinsson, L. (1993). The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann. Neurol. 33, 48-56.
20. Gowers, W.R. (1888). A Manual of Diseases of the Nervous System. Volume 2. Churchill, London, UK.
21. Guiloff, R.J. and Fruns, M. (1988). Limb pain in migraine and cluster headache. J. Neurol. Neurosurg. Psychiatry 51, 1022-1031.
22. Hadjikhani, N. et al. (2001). Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc. Natl. Acad. Sci. USA 98, 4687-4692.
23. Headache Classification Committee of the International Headache Society (1988). Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8 (suppl. 7), 1-96.
24. Ho, T.W. et al. (2008). Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology 70, 1304-1312.
25. Hubel, D.H. and Wiesel, T.N. (1959). Receptive fields of single neurons in the cat's striate cortex. J. Physiol. 148, 574-591.
26. Juhasz, G. et al. (2005). Parallel decrease in plasma calcitonin generelated peptide (CGRP) concentration and migraine headache after sumatriptan treatment. Cephalalgia 25, 179-183.
27. Kropp, P. and Gerber, W.D. (1993). Is increased amplitude of contingent negative variation in migraine due to cortical hyperactivity or to reduced habituation? Cephalalgia 13, 37-41.
28. Kruuse, C. et al. (2003). Migraine can be induced by sidenafil without changes in middle cerebral artery diameter. Brain 126, 241-247.
29. th edition. Elsevier, Philadelphia.
30. Lashley, KS (1941). Patterns of cerebral integration indicated by the scotomas of migraine. Arch. Neurol. Psychiatry 46, 331-339.
31. Lassen, L.H. et al. (1998). Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks. Cephalalgia 18, 27-32.
32. Latham, P.M. (1872). Clinical lecture on nervous or sick-headache. BMJ 1, 336-337.
33. Leão, A. (1944). Spreading depression of activity in the cerebral cortex. J. Neurophysiol. 7, 359-370.
34. th Annual Scientific Meeting of the American Headache Society.
35. Liveing, E. (1873). On Megrim, Sick-Headache and Some Allied Disorders. A Contribution to the Pathology of Nerve-Storms. Churchill, London, UK.
36. Maertens de Noordhout, A. et al (1992). Percutaneous magnetic stimulation of the motor cortex in migraine. Electroenceph. Clin. Neurophysiol. 85, 110-115.
37. nd edition. Alkat Neuroscience, West Flamborough, Canada.
38. th Annual Scientific Meeting of the American Headache Society.
39. Moskowitz, M.A. et al. (1988). Intra- and extracraniovascular nociceptive mechanisms and the pathogenesis of head pain. In: Basic Mechanisms of Headache. Olesen, J and Edvinsson, L. (Eds), 429-437. Elsevier Science Publishers, Amsterdam, The Netherlands.
40. Moskowitz, M. A. (1992). Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol. Sci. 13, 307-311.
41. Olesen, J. et al. (1981). Focal hyperemia followed by spreading oligemia and impaired activation of rCfBF in classic migraine. Ann. Neurol. 9, 344-352.
42. Olesen, J. et al. (1990). Timing and topography of cerebral blood flow, aura, and headache dauing migraine attacks. Ann. Neurol. 28, 791-798.
43. Olesen, J. et al (1993). Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. Neuroreport 4, 1027-1030.
44. Olesen, J. et al. (2004). Calcitonin gene-related peptide receptor antagonist BIBN 4096BS for the acute treatment of migraine. N. Eng. J. Med. 350, 1104-1110.
45. 2+ channel gene CACNL1A4. Cell 87, 543-582.
46. Penfield, W. and Boldrey, E. (1937). Somatic motor and sensory representation in the cerebral cortex of man as studied by electrical stimulation. Brain 60, 389-343.
47. Ray, B.S. and Wolff, H.G. (1940). Experimental studies on headache: pain-sensitive structures of the head and their significance in headache. Arch. Surg. 41, 813-856.
48. Sarchelli, P et al. (2000). Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia 20, 907-918.
49. Schoenen, J. et al. (1995). Potentiation instead of habituation characterizes visual evoked potentials in migraine patients between attacks. Eur. J. Neurol 2, 115-122.
50. Stepien, A et al (2003). Effect of rizatriptan on CGRP level in migraine. Cephalalgia 23, 738.
51. Upton, A. and McComas, A. (2005). Abolition of migraine by transcranial magnetic stimulation. Can. J. Neurol. Sci. 32, P-159.
52. Van der Kamp, W. et al. (1996). Interictal cortical hyperexcitability in migraine patients demonstrated with transcranial magnetic stimulation. J. Neurol. Sci. 48, 1462-1464.
53. Waeber, C. and Moskowitz, M.A. (2005). Migraine as an inflammatory disorder. Neurology 64, S9-S15.
54. Wang, W. and Schoenen, J. (1998). Interictal potentiation of passive 'oddball' auditory even-related potentials in migraine. Cephalalgia 18, 261-265.
55. Wei, E.P. et al. (1992). Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline vertebral arterioles. Circ. Res. 70, 1313-1319.
56. Weiller, C. et al. (1995). Brain stem activation in spontaneous human migraine attacks. Nature Med. 1, 658-660.
57. Wolff, H.G. (1948). Headache and Other Head Pain. Oxford University Press, Oxford, UK.
58. Woods, R.P. et al. (1994). Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N. Eng. J. Med. 331, 1689-1692.